Cargando…

Association of markers of systemic and local inflammation with prognosis of patients with rectal cancer who received neoadjuvant radiotherapy

PURPOSE: The inflammatory status of patients with cancer appears to affect cancer progression and patient prognosis. We examined the characteristics of cancer-associated systemic and local inflammation and its impact on the overall survival (OS) of patients with locally advanced rectal cancer (LARC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xueqing, Li, Jinluan, Peng, Qingqin, Huang, Yunxia, Tang, Lirui, Zhuang, Qingyang, Lin, Feifei, Lin, Xijin, Du, Kaixin, Wu, Junxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307689/ https://www.ncbi.nlm.nih.gov/pubmed/30636893 http://dx.doi.org/10.2147/CMAR.S187559

Ejemplares similares

A Modified NAR Scoring Model Incorporating Immune Infiltration Characteristics to Better Predict Long-Term Survival Following Neoadjuvant Radiotherapy in Rectal Cancer
por: Zhang, Xueqing, et al.
Publicado: (2023)

Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis
por: Du, Kaixin, et al.
Publicado: (2019)

Tumor cell PD-L1 predicts poor local control for rectal cancer patients following neoadjuvant radiotherapy
por: Shao, Lingdong, et al.
Publicado: (2017)

Prognostic nomogram based on the metastatic lymph node ratio for gastric neuroendocrine tumour: SEER database analysis
por: Li, Jinluan, et al.
Publicado: (2020)

Characteristics and prognostic factors of colorectal mucinous adenocarcinoma with signet ring cells
por: Kong, Xiangquan, et al.
Publicado: (2017)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Evaluation of the ability of fatty acid metabolism signature to predict response to neoadjuvant chemoradiotherapy and prognosis of patients with locally advanced rectal cancer
por: Zhou, Han, et al.
Publicado: (2022)

A modified melanoma-molGPA scoring model: assessment of survival after and efficacy of different radiotherapy modalities in patients with melanoma brain metastases
por: Wu, Qian, et al.
Publicado: (2023)

Identifying the long-term survival beneficiary of preoperative radiotherapy for rectal cancer in the TME era
por: Wang, Lei, et al.
Publicado: (2022)

Neoadjuvant radiotherapy for rectal cancer management
por: Feeney, Gerard, et al.
Publicado: (2019)

High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
por: Tian, Yu-Feng, et al.
Publicado: (2017)

Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
por: Repetto, Ombretta, et al.
Publicado: (2017)

Prognostic Impact of Carcinoembryonic Antigen Levels in Rectal Cancer Patients Who Had Received Neoadjuvant Chemoradiotherapy
por: Joo, Jung Il, et al.
Publicado: (2021)

Temporal determinants of tumour response to neoadjuvant rectal radiotherapy
por: Koo, Kendrick, et al.
Publicado: (2021)

Trends with neoadjuvant radiotherapy and clinical staging for those with rectal malignancies
por: Reddy, Sanjay S, et al.
Publicado: (2017)

Nomogram for prognosis of elderly patients with cervical cancer who receive combined radiotherapy
por: Chen, Wenjuan, et al.
Publicado: (2023)

Effects of neoadjuvant chemotherapy with or without intensity‐modulated radiotherapy for patients with rectal cancer
por: He, Fang, et al.
Publicado: (2020)

A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer
por: Xiao, Yu, et al.
Publicado: (2023)

Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response
por: Huang, Yu-Ming, et al.
Publicado: (2022)

Factors relevant to the prognosis of patients with esophageal cancer who received intensity‐modulated radiotherapy
por: Yin, Hongmei, et al.
Publicado: (2018)

Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy
por: Li, Xinxing, et al.
Publicado: (2017)

Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
por: Wu, San-Gang, et al.
Publicado: (2015)

The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer
por: Wang, Lei, et al.
Publicado: (2021)

Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer—Systematic Review
por: Smolskas, Edgaras, et al.
Publicado: (2022)

Clinical Effect of Radiotherapy Combined with Capecitabine after Neoadjuvant Therapy for Rectal Cancer
por: Zhang, Qibo, et al.
Publicado: (2021)

Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer
por: Tokuhara, Katsuji, et al.
Publicado: (2022)

Effects of Neoadjuvant Radiotherapy on Postoperative Complications in Rectal Cancer: A Meta-Analysis
por: Yang, Jianguo, et al.
Publicado: (2022)

Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
por: Wang, Jian, et al.
Publicado: (2021)

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
por: Xu, Hongen, et al.
Publicado: (2019)

A blind randomized validated convolutional neural network for auto‐segmentation of clinical target volume in rectal cancer patients receiving neoadjuvant radiotherapy
por: Wu, Yijun, et al.
Publicado: (2021)

Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age
por: Wu, Leilei, et al.
Publicado: (2017)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
por: Mihmanlı, Mehmet, et al.
Publicado: (2016)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Prognosis and value of preoperative radiotherapy in locally advanced rectal signet-ring cell carcinoma
por: Ling, Chun-Run, et al.
Publicado: (2017)

The evaluation of the oxidative stress for patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Serbanescu, GL, et al.
Publicado: (2017)

Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
por: Ho, Vincent, et al.
Publicado: (2018)

Prognostic Nomogram for Rectal Cancer Patients With Tumor Deposits
por: Zhong, Xiaohong, et al.
Publicado: (2022)

Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature
por: Delishaj, Durim, et al.
Publicado: (2021)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Zhang, Lu-Ning, et al.
Publicado: (2015)

Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation
por: Zhou, Han, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rahannc5tir4teq91jrq3ecf3n